£1.5M
1nhaler secures £1.5m in seed follow-on funding led by Archangels to advance its paper inhaler platform
The financing will support clinical material manufacture and preparation for regulatory studies ahead of a target marketing authorisation application.
"This additional funding represents strong continued confidence in our technology platform and our progress towards commercialisation. The support from Archangels, Scottish Enterprise and BBB Investments is enabling us to advance our clinical and manufacturing capabilities as we work towards regulatory approval."
Archangels + 2 others